This review explores the evolution of lipid‐based nanoparticles (LBNPs) for drug delivery
(DD). Herein, LBNPs are classified into liposomes and cell membrane‐based nanoparticles …

Sonodynamic therapy (SDT) has been developed as a promising alternative therapeutic
modality for cancer treatment, involving the synergetic application of sonosensitizers and …

Liposomes, as a colloidal drug delivery system dating back to the 1960s, remain a focal
point of extensive research and stand as a highly efficient drug delivery method. The …

Addressing infectious conditions presents a formidable challenge, primarily due to the
escalating issue of bacterial resistance. This, coupled with limited financial resources and …

Baicalin (BCL), a well-known flavonoid molecule, has numerous therapeutic applications.
However, its low water solubility and bioavailability limit its applicability. Microfluidics is a …

Liver disorders present a significant global health challenge, necessitating the exploration of
innovative treatment modalities. Liposomal nanocarriers have emerged as promising …

Liposomes represent a promising class of drug delivery systems that enhance the
therapeutic efficacy and safety of various pharmaceutical agents. Also, they offer numerous …

Background Cationic liposomes represent a promising non-viral carrier platform for gene
delivery. The successful intracellular delivery of genes to the target cell is highly influenced …

Multiple sclerosis (MS) is a neuroimmunological disorder which causes axonal damage,
demyelination and paralysis. Although numerous therapeutics have been developed for the …

Nanomedicine has emerged as a valuable treatment and diagnosis option, due to its ability
not only to address formulation challenges associated with new therapeutic moieties, but …